What it changes

1 change to H.R. 3076 · shown in the bill's text

Adds a section
  1. Adds SEC. 210. PROHIBITION ON MAILING COVID-19 TESTS MANUFACTURED IN CHINA UNDER FEDERAL PROGRAM TO DISTRIBUTE FREE TESTS at the end of title II

    Adds a section

    In H.R. 3076 · Placed on Calendar Senate

    (e) Effective Date.--This section and the amendments made by this section shall take effect on the date that is 180 days after the date of enactment of this Act.

    Inserted: SEC. 210. PROHIBITION ON MAILING COVID-19 TESTS MANUFACTURED IN CHINA UNDER FEDERAL PROGRAM TO DISTRIBUTE FREE TESTS.

    Inserted: In carrying out the Federal program to distribute free at-home tests for SARS-CoV-2 announced on January 14, 2022, the Postal Service shall treat any at-home test for SARS-CoV-2 that was manufactured, in whole or in part, in the People's Republic of China as nonmailable matter under section 3001 of title 39, United States Code.

    Original wording

    At the end of title II, add the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

SA 4934. Mr. MARSHALL (for himself and Mr. Scott of Florida) submitted an amendment intended to be proposed by him to the bill H.R. 3076, to provide stability to and enhance the services of the United States Postal Service, and for other purposes; which was ordered to lie on the table; as follows:

At the end of title II, add the following:

SEC. 210. PROHIBITION ON MAILING COVID-19 TESTS MANUFACTURED IN CHINA UNDER FEDERAL PROGRAM TO DISTRIBUTE FREE TESTS.

In carrying out the Federal program to distribute free at-home tests for SARS-CoV-2 announced on January 14, 2022, the Postal Service shall treat any at-home test for SARS-CoV-2 that was manufactured, in whole or in part, in the People's Republic of China as nonmailable matter under section 3001 of title 39, United States Code.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

Floor Latest Action

Senate amendment submitted

March 1, 2022